All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 1.8mg: What To Expect

What to expect on liraglutide 1.8mg. Covers appetite changes, side effects, early weight loss acceleration, and how this dose bridges the gap between...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

What to expect on liraglutide 1.8mg. Covers appetite changes, side effects, early weight loss acceleration, and how this dose bridges the gap between introductory and therapeutic levels.

Liraglutide 1.8mg is the third step in the five-step titration and a important dose level where the medication's appetite-suppressing effect becomes clearly noticeable for most patients. At 1.8mg, you can expect meaningful appetite reduction, a real decrease in food noise and cravings, and the beginning of genuine weight loss. This dose is also the maximum for the diabetes indication (Victoza), so it has an extensive safety record spanning years of clinical use.

1.8mg: Where Treatment Gets Real

If 0.6mg was the on-ramp and 1.2mg was first gear, 1.8mg is where you start to feel the engine. At 60 percent of the target dose, most patients notice a clear shift in their relationship with food:

  • Meals genuinely satisfy with smaller portions
  • The gap between meals feels comfortable rather than painful
  • Cravings lose their urgency. You may still want certain foods, but the compulsive pull weakens.
  • Food noise (constant mental preoccupation with eating) begins to quiet

This is the dose where many patients first think, "Okay, this is actually working." If you felt nothing at 0.6mg and very little at 1.2mg, 1.8mg is likely to change that. liraglutide 1.2mg what to expect

The First Week at 1.8mg

  • Day 1: First injection at the new dose. The 50 percent increase from 1.2mg is the largest proportional step remaining in the titration. Appetite suppression noticeably deepens within hours for some patients.
  • Days 2 to 3: Steady-state levels at 1.8mg are reached. Nausea may return for a brief window, affecting approximately 20 to 30 percent of patients. For most, it's milder than any nausea experienced at earlier dose increases.
  • Days 3 to 5: The appetite effect is in full gear. Meals feel smaller and more satisfying. Some patients report that the thought of eating large portions becomes unappealing.
  • Days 6 to 7: Adaptation is complete for most patients. The 1.8mg effect feels stable and predictable. If GI symptoms persist, consider an extra week before moving to 2.4mg.

Weight Loss at 1.8mg

This is where the weight loss curve begins to steepen:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 1.8mg: What To Expect
  • During the 1.8mg week: 1 to 3 pounds lost
  • Cumulative after 3 weeks of treatment: 3 to 7 pounds total
  • Long-term at 1.8mg (diabetes data): Approximately 4 to 5 percent of body weight over 6 months

For patients using 1.8mg as the maximum Victoza dose for diabetes, this level of weight loss is a welcome secondary benefit. For weight management patients titrating toward 3.0mg, the 1.8mg results preview what the full dose will deliver at greater intensity. liraglutide 1.8mg weight loss average

Blood Sugar Effects at 1.8mg

At the maximum Victoza dose, liraglutide's glucose-lowering effect is fully expressed:

  • A1C reduction of approximately 1.0 to 1.5 percentage points in patients with type 2 diabetes
  • Improved fasting plasma glucose
  • Reduced post-meal glucose spikes
  • Enhanced insulin sensitivity

For patients without diabetes, these effects manifest as more stable energy levels throughout the day. The blood sugar roller coaster that drives mid-afternoon cravings becomes smoother.

Practical Life at 1.8mg

Compared to the first two weeks of treatment, several practical shifts emerge at 1.8mg:

  • Meal planning becomes easier: With clearer appetite control, you can plan meals around nutrition rather than cravings. Protein, vegetables, and whole foods become the natural choices when you're eating because you should rather than because you're driven to.
  • Social eating adjusts: At restaurants, you may find you can't finish half your usual order. Consider appetizer portions or sharing entrees.
  • Pen usage increases: At 1.8mg daily, each Saxenda pen (18mg total) lasts about 10 days. Make sure your supply is adequate. Contact provider for current pricing
  • Hydration matters more: With less food intake, you get less water from food. Consciously drinking 64 to 80 ounces daily helps prevent constipation and headaches.

Medical References

  1. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]

Frequently Asked Questions

Is 1.8mg enough for weight loss, or do I need to continue to 3.0mg?
For most weight management patients, 1.8mg isn't the final dose. The SCALE trial[1] showed that 3.0mg produces roughly twice the weight loss of 1.8mg over time. But some patients achieve satisfactory results at 1.8mg and their prescriber may allow them to stay there. liraglutide 1.8mg how long to stay on
I am having more nausea at 1.8mg than at previous doses. Is that normal?
Yes. The 1.8mg dose represents a meaningful jump in GLP-1 receptor activation. Nausea at this level is more common than at lower doses but is typically brief (2 to 4 days). If it persists beyond one week, discuss options with your prescriber. liraglutide 1.8mg side effects
Can I stay at 1.8mg if I am using Saxenda?
Your prescriber may allow it, but the FDA-approved target dose for Saxenda is 3.0mg. Staying at 1.8mg means accepting a lower level of weight loss effectiveness. Some prescribers support this if you're losing weight and the side effects at higher doses are problematic.
How does liraglutide 1.8mg compare to semaglutide 0.5mg?
Semaglutide 0.5mg (an early titration dose for Ozempic or Wegovy) produces comparable or slightly stronger appetite suppression than liraglutide 1.8mg, despite being a lower absolute dose. Semaglutide is a more potent GLP-1 agonist.

This article is for informational purposes only and doesn't constitute medical advice. Continue your titration as directed by your prescriber.

Contact provider for current pricing Contact provider for current pricing

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Liraglutide 1.8mg: What To Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 1.8mg: What To Expect, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-04-01
Page metadata
Ozempic official website
Official source
Retatrutide official website
Official source
Saxenda official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Wegovy official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Liraglutide 1.8mg: What To Expect research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.